ArticleLife (Basel, Switzerland)2023

IGFBP-6 Alters Mesenchymal Stromal Cell Phenotype Driving Dasatinib Resistance in Chronic Myeloid Leukemia.

Daniela Cambria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.